Salazar-Conde JC, Arcos-Streber GA, García-Martínez DA

Language: Spanish
References: 12
Page: 246-250
PDF size: 231.48 Kb.

ABSTRACT

Introduction: drugs are currently used to reduce intraoperative bleeding, transfusion of blood products such as tranexamic acid, which is an antifibinolytic lysine analogue, and desmopressin, which acts by autologously increasing factor VIII and VWF in healthy individuals. Objective: demonstrate the efficacy of the use and safety of tranexamic acid vs desmopressin to reduce the transfusion of blood components in patients undergoing elective total abdominal hysterectomy. Material and methods: 72 patients were studied, divided into two groups (36 patients each one) randomly assigned to receive tranexamic acid 10 mg/kg weight or desmopressin 0.3 mg/kg weight, both intravenously 20 minutes prior to the surgical event. Results: the comparison of tranexamic acid against desmopressin for the reduction of intraoperative bleeding, 100% of the patients who were administered tranexamic acid did not require transfusion of blood products and presented 100% effectiveness, being statistically significant with a value of p < 0.05. Conclusions: the administration of tranexamic acid was more effective in reducing the administration of blood products in patients undergoing elective total abdominal hysterectomy.

REFERENCES

1. Hollman-Montiel JP, Rodríguez AG. Complicaciones de la histerectomía total abdominal ginecológica por patología benigna. Arch Inv Mat Inf. 2014;6:25-30.

2. Brenner A, Ker K, Shakur-Still H, Roberts I. Tranexamic acid for post-partum haemorrhage: what, who and when. Best Pract Res Clin Obstet Gynaecol. 2019;61:66-74.

3. Piamo Morales AJ, Rojas MA. Uso de ácido tranexámico en las hemorragias. Rev Cubana Cir. 2018;57:e705.

4. Topsoee MF, Bergholt T, Ravn P, Schouenborg L, Moeller C, Ottesen B, et al. Anti-hemorrhagic effect of prophylactic tranexamic acid in benign hysterectomy-a double-blinded randomized placebo-controlled trial. Am J Obstet Gynecol. 2016;215:72.e1-8.

5. Reed MR, Woolley LT. Uses of tranexamic acid. Contin Educ Anaesth Crit Care Pain. 2015;15:32-37. doi: 10.1093/bjaceaccp/mku009.

6. Lier H, Maegele M, Shander A. Tranexamic acid for acute hemorrhage: a narrative review of landmark studies and a critical reappraisal of its use over the last decade. Anesth Analg. 2019;129:1574-1584.

7. Roberts I, Shakur H, Coats T, Hunt B, Balogun E, Barnetson L, et al. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. Health Technol Assess. 2013;17:1-79.

8. Ng W, Jerath A, W?sowicz M. Tranexamic acid: a clinical review. Anaesthesiol Intensive Ther. 2015;47:339-350.

9. López García L. Utilidad hemostática de la desmopresina en la desmopresina en la histerectomía abdominal en pacientes con miomatosis uterina sintomática [Tesis]. México: Universidad Nacional Autónoma de México; 2003.

10. Shao H, Kuang LT, Hou WJ, Zhang T. Effect of desmopressin administration on intraoperative blood loss and quality of the surgical field during functional endoscopic sinus surgery: a randomized, clinical trial. BMC Anesthesiol. 2015;15:53. doi: 10.1186/s12871-015-0034-8.

11. Leissinger C, Carcao M, Gill JC, Journeycake J, Singleton T, Valentino L. Desmopressin (DDAVP) in the management of patients with congenital bleeding disorders. Haemophilia. 2014;20:158-167.

12. Barba EJR, Suárez MEC. Transfusión de paquete globular. Del beneficio clínico real a la inadecuada prescripción. Rev Mex Patol Clin Med Lab. 2015;62:46-54.